Skip to main content
RAPS Convergence 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Pre-Registration or Sign-up
Requires Pre-Registration or Sign-up
Additional Registration Fee
Additional Registration Fee
Invitation Only
Invitation Only
Student Program
Student Program
Networking Opportunity
Networking Opportunity
RAPS Focus Area
RAPS Focus Area
Back

Amrit Ray, MD, MBA

CEO
Principled Impact

Amrit Ray, MD, MBA is a senior biopharmaceutcal R&D Executive and Corporate Board Director at multiple life sciences companies. Prior to his board director roles, Dr. Ray was Global President, Head of R&D, and Executive Leadership Team member at Pfizer Upjohn. He has held multiple C-suite roles at major companies, including as the Chief Medical Officer at Janssen (Johnson & Johnson), and as the Chief Patient Officer at Biohaven (acquired by Pfizer, 2022).

Dr. Ray is passionate about solving the toughest medical challenges to bring extraordinary impact to the lives of patients and families around the world. He has over 25 years of healthcare experience ranging from physician providing patient care to Fortune 100 corporate executive, public and private company board director, and private equity advisor. He is a dedicated advocate for patients and committed to building winning, diverse teams that use scientific insights to advance R&D pipelines and drive access to medicines.

As a physician researcher, he has applied deep functional experience across R&D, medical affairs and RWE to advance pipelines, registration, launch, access and high patient impact for several transformational medicines in Neuroscience, Oncology, Immunology, Cardio-metabolism and other areas. As a business executive, he has played instrumental roles in multiple, successful corporate M&A transactions, and has experience as a Senior Advisor to Bain Capital private equity. He began his career serving as a hospital doctor delivering patient care in Britain’s National Health Service. He is a Visiting Professor in the Faculty of Medical Sciences, Newcastle University, UK.

Disclosure information not submitted.

Presentation(s):